VIVO News and Press, Meridian Bioscience Inc. From 02/23/21

CINCINNATI, Feb. 23, 2021 (GLOBE NEWSWIRE) -- Meridian Bioscience, Inc. (NASDAQ: VIVO), a provider of diagnostic testing solutions and life science raw materials, provided a further update on its application for Emergency Use Authorization (EUA) with the U.S. Food and Drug Administration (F...

Stock market indices stand to finish mixed after a holiday-shortened week where Congressional hearings around GameStop (GME) dominated headlines. The Nasdaq (COMP) may eke out a small gain for the week, while the S&P 500 (SP500) is down about 0.8% at the time of this writing. Dow Industri...

Quidel Corporation ([[QDEL]] -10.9%) has failed to meet the consensus revenue estimates in Q4 2020 despite the surging pandemic driving a ~80.6% YoY sequential growth in revenue from COVID-19 products.Today, the stock is leading a broader selloff among COVID-19 test makers after Evercore ISI ...

While small-cap stocks are usually considered relatively risky investments, some small-cap stocks hold explosive growth potential. Because most popular stocks are now trading at lofty valuations, it could be wise to bet on small-cap players like Atkore International Group (ATKR), Meridian Bio...

Meridian Bioscience (VIVO) has seen its stock soar on the back of rising demand for COVID tests. While testing should continue for some time, is the growth already factored into the price? Or will the rally continue? Read more to find out. Meridian Bioscience ( VIVO ) has soared over t...

The FDA late Feb. 12 requested that Meridian Bioscience (VIVO) provide additional information for an Emergency Use Authorization application for its SARS-CoV-2 molecular diagnostic test based on the Revogene platform.The company says it plans to send a response to the agency later today.Merid...

CINCINNATI, Feb. 16, 2021 (GLOBE NEWSWIRE) -- Meridian Bioscience, Inc. (NASDAQ: VIVO), a provider of diagnostic testing solutions and life science raw materials, provided an update on its application for Emergency Use Authorization (EUA) with the U.S. Food and Drug Administration (FDA) for...

Two new breakout stocks for Week 6 of 2021 with better than 10% short-term upside potential. This past week three out of four stocks gained over 10% with VXRT gaining over 162% before pulling back midweek with average -2.96% portfolio declines to the close. 2021 MDA portfolio retu...

The following slide deck was published by Meridian Bioscience, Inc. in conjunction with their 2021 Q1 earnings call. For further details see: Meridian Bioscience, Inc. 2021 Q1 - Results - Earnings Call Presentation

Image source: The Motley Fool. Meridian Bioscience Inc (NASDAQ: VIVO) Q1 2021 Earnings Call Feb 5, 2021 , 10:00 a.m. ET Operator Continue reading For further details see: Meridian Bioscience Inc (VIVO) Q1 2021 Earnings Call Transcript